Literature DB >> 9185996

Bcl-x expression influences keratinocyte cell survival but not terminal differentiation.

J C Pena1, E Fuchs, C B Thompson.   

Abstract

The epidermis is characterized by the continual turnover of its basic cellular unit, the keratinocyte. To determine whether genes known to regulate apoptosis could affect keratinocyte biology, transgenic mice overexpressing bcl-xL or bcl-xS under the control of the human keratin 14 promoter were generated. The maturation process and cellularity of the stratified epidermis were not compromised in the transgenic mice. Transgene function was demonstrated by enhanced cell survival of bcl-xL transgenic versus wild-type primary keratinocyte cultures treated with etoposide. To test the response of these mice to genotoxic damage, wild-type and transgenic mice were irradiated with UV light. The bcl-xL transgenic mice showed a dramatically increased resistance to irradiation, whereas the bcl-xS transgenic mice showed an increased sensitivity to irradiation. In contrast, neither transgene influenced the rate of would repair. Interestingly, endogenous Bcl-x was rapidly induced in keratinocytes adjacent to the would. Taken together, these findings demonstrate that although the terminal differentiation program is not altered by Bcl-x, acute stress responses within the skin can be influenced by regulators of apoptosis such as Bcl-x.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185996

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  9 in total

Review 1.  Keratinocyte apoptosis in epidermal development and disease.

Authors:  Deepak Raj; Douglas E Brash; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

2.  Killing of sarcoma cells by proapoptotic Bcl-X(S): role of the BH3 domain and regulation by Bcl-X(L).

Authors:  R S Mitra; M A Benedict; D Qian; K E Foreman; D Ekhterae; B J Nickoloff; G Nuñez
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

3.  The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).

Authors:  B S Chang; A Kelekar; M H Harris; J E Harlan; S W Fesik; C B Thompson
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

4.  NF-kappaB determines localization and features of cell death in epidermis.

Authors:  C S Seitz; R A Freiberg; K Hinata; P A Khavari
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.

Authors:  D Grossman; P J Kim; O P Blanc-Brude; D E Brash; S Tognin; P C Marchisio; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  Naringenin protects HaCaT human keratinocytes against UVB-induced apoptosis and enhances the removal of cyclobutane pyrimidine dimers from the genome.

Authors:  Mohamed A El-Mahdy; Qianzheng Zhu; Qi-En Wang; Gulzar Wani; Srinivas Patnaik; Qun Zhao; El-Shaimaa Arafa; Bassant Barakat; Safita N Mir; Altaf A Wani
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

7.  Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis.

Authors:  Dae Joon Kim; Ken Kataoka; Shigetoshi Sano; Kevin Connolly; Kaoru Kiguchi; John DiGiovanni
Journal:  Mol Carcinog       Date:  2009-10       Impact factor: 4.784

8.  Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias.

Authors:  Anneli R Bowen; Adrianne N Hanks; Kelley J Murphy; Scott R Florell; Douglas Grossman
Journal:  Am J Dermatopathol       Date:  2004-06       Impact factor: 1.533

9.  Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis.

Authors:  D J Kim; J M Angel; S Sano; J DiGiovanni
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.